% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • rojospan rojospan Apr 25, 2013 9:22 PM Flag

    Best buyout target



    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bio_trader Apr 26, 2013 12:50 AM Flag

      CFO seems to think so, that's why he sold his shares at $81.50 haha. Maybe a buyout at $40 after it tanks to $30?

    • Instead of a buyout , long term VRTX investors would do better for the company to stay independent, with the stock likely to spike higher in the short to medium term with the eventual announcement of lucrative partnerships with larger pharmas to devleop VX 787 and VX 509. Then watch the stock fly as clinical trials start to be reported through the remainder of the year. Three Kalydeco monotherapy Phase 3 trials in non G551 mutations will be out this summer, and VX 509 Phase 2 trial in RA this fall, along with VX 135 all oral hep C treatments being tested with BMY, JNJ and GSK compounds. And of course, Phase 3 809/770 six month interim data due either at the end of this year or start of 2014, to allow NDA submission. With a nearly $18 billion market cap, expect addition of VRTX to the S&P 500, with the subsequent required purchase of VRTX by all the index mutual funds. Enjoy the ride.......

83.23+3.52(+4.42%)Feb 12 4:00 PMEST